Abstract

Background: Zeta-Chain Associated Protein Kinase 70 kDa (ZAP-70) deficiency is a rare combined immunodeficiency (CID) caused by recessive homozygous/compound heterozygous loss-of-function mutations in the ZAP70 gene. Patients with ZAP-70 deficiency present with a variety of clinical manifestations, particularly recurrent respiratory infections and cutaneous involvements. Therefore, a systematic review of ZAP-70 deficiency is helpful to achieve a comprehensive view of this disease.Methods: We searched PubMed, Web of Science, and Scopus databases for all reported ZAP-70 deficient patients and screened against the described eligibility criteria. A total of 49 ZAP-70 deficient patients were identified from 33 articles. For all patients, demographic, clinical, immunologic, and molecular data were collected.Results: ZAP-70 deficient patients have been reported in the literature with a broad spectrum of clinical manifestations including recurrent respiratory infections (81.8%), cutaneous involvement (57.9%), lymphoproliferation (32.4%), autoimmunity (19.4%), enteropathy (18.4%), and increased risk of malignancies (8.1%). The predominant immunologic phenotype was low CD8+ T cell counts (97.9%). Immunologic profiling showed defective antibody production (57%) and decreased lymphocyte responses to mitogenic stimuli such as phytohemagglutinin (PHA) (95%). Mutations of the ZAP70 gene were located throughout the gene, and there was no mutational hotspot. However, most of the mutations were located in the kinase domain. Hematopoietic stem cell transplantation (HSCT) was applied as the major curative treatment in 25 (51%) of the patients, 18 patients survived transplantation, while two patients died and three required a second transplant in order to achieve full remission.Conclusion: Newborns with consanguineous parents, positive family history of CID, and low CD8+ T cell counts should be considered for ZAP-70 deficiency screening, since early diagnosis and treatment with HSCT can lead to a more favorable outcome. Based on the current evidence, there is no genotype-phenotype correlation in ZAP-70 deficient patients.

Highlights

  • Protein-tyrosine kinases (PTKs) are known to have an integral role in T cell activation

  • A comprehensive search, limited to articles written in the English language, was performed using PubMed, Web of Science, and Scopus databases, applying the following search terms: “Zeta chain-associated protein of 70 kilo Daltons” or “Zeta chain-associated Protein Tyrosine Kinase” or “Zap-70” or “ZAP70” or “ZAP70 mutation” or “Zeta(ζ)-Chain Associated Protein Kinase 70 kDa (ZAP-70) Protein Tyrosine Kinase” or “ZAP-70 deficiency”; combined with the following search terms, using “AND” command: “Immunodeficiency” or “Severe Combined Immunodeficiency” or “severe CID (SCID)” or “Combined Immunodeficiency” or “CID” or “Primary Immunodeficiency” or “PID” or “lymphopenia” or “CD8+ T-cell lymphopenia” or “hypomorphic mutations in severe combined immunodeficiency disease.”

  • All fulltext manuscripts were assessed for eligibility criteria: written in English, conducted on human subjects, reporting at least one patient with ZAP-70 deficiency diagnosis, and detailed description of epidemiological, clinical, and immunological features associated with genetic mutations

Read more

Summary

Introduction

Protein-tyrosine kinases (PTKs) are known to have an integral role in T cell activation. Activated ZAP70 regulates motility, adhesion and cytokine expression of specific lymphocytes, mainly γδT-cells, memory CD8+ T-cells, NK-cells, MAIT T-cells, naive CD8+ T-cell, regulatory T-cells, memory CD4+ T-cells, and naive CD4+ T-cells. This protein contributes to the development and activation of B cells. Deficiency of ZAP-70 causes a combined immunodeficiency (CID), presenting with recurrent infections, slightly milder than those with recessive forms of severe CID (SCID) [2]. Zeta-Chain Associated Protein Kinase 70 kDa (ZAP-70) deficiency is a rare combined immunodeficiency (CID) caused by recessive homozygous/compound heterozygous loss-of-function mutations in the ZAP70 gene. A systematic review of ZAP-70 deficiency is helpful to achieve a comprehensive view of this disease

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.